Humana Inc: Form 10-Q for the period ended Jun 30, 2012
Filed with the SEC on Aug 1, 2012 and accepted by EDGAR at Aug 1, 2012, 10:37 ET.
Management's discussion and analysis
As filed, 1,497 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(a) None.
(b) N/A
(c) The following table provides information about purchases by us during the three months ended June 30, 2012 of equity securities that are registered by us pursuant to Section 12 of the Exchange Act:
| Period | Total Number of Shares Purchased (1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)(2) | Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (1) |
|---|---|---|---|---|
| April 2012 | 0 | 0 | 0 | $1,000,000,000 |
| May 2012 | 1,579,000 | 79.94 | 1,579,000 | 873,816,319 |
| June 2012 | 0 | 0 | 0 | 873,816,319 |
| Total | 1,579,000 | $79.94 | 1,579,000 | $873,816,319 |
(1) As announced on April 30, 2012, in April 2012, the Board of Directors replaced its previously approved share repurchase authorization of up to $1 billion with a new authorization for repurchases of up to $1 billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring on June 30, 2014. Under this share repurchase authorization, shares may be purchased from time to time at prevailing prices in the open market, by block purchases, or in privately-negotiated transactions, subject to certain regulatory restrictions on volume, pricing, and timing. As of July 31, 2012, the remaining authorized amount under this authorization totaled $874 million.
(2) Excludes 18,163 shares repurchased in connection with employee stock plans.
Market risk
As filed, 2,089 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our earnings and financial position are exposed to financial market risk, including those resulting from changes in interest rates.
Interest rate risk also represents a market risk factor affecting our consolidated financial position due to our significant investment portfolio, consisting primarily of fixed maturity securities of investment-grade quality with a weighted average S&P credit rating of AA at June 30, 2012. Our net unrealized position improved $97 million from a net unrealized gain position of $525 million at December 31, 2011 to a net unrealized gain position of $622 million at June 30, 2012. At June 30, 2012, we had gross unrealized losses of $13 million on our investment portfolio primarily due to an increase in market interest rates and tighter liquidity conditions in the current markets than when the securities were purchased, and as such, there were no material other-than-temporary impairments during 2012. While we believe that these impairments are temporary and we currently do not have the intent to sell such securities, given the current market conditions and the significant judgments involved, there is a continuing risk that future declines in fair value may occur and material realized losses from sales or other-than-temporary impairments may be recorded in future periods.
Duration is the time-weighted average of the present value of the bond portfolio’s cash flow. Duration is indicative of the relationship between changes in fair value and changes in interest rates, providing a general indication of the sensitivity of the fair values of our fixed maturity securities to changes in interest rates. However, actual fair values may differ significantly from estimates based on duration. The average duration of our investment portfolio, including cash and cash equivalents, was approximately 3.2 years as of June 30, 2012 and 3.9 years as of December 31, 2011. Based on the duration including cash equivalents, a 1% increase in interest rates would generally decrease the fair value of our investment portfolio by approximately $431 million.
Controls and procedures
As filed, 1,274 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Under the supervision and with the participation of our Chief Executive Officer, or CEO, our Chief Financial Officer, or CFO, and our Principal Accounting Officer, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures for the quarter ended June 30, 2012.
Based on our evaluation, our CEO, CFO, and Principal Accounting Officer concluded that our disclosure controls and procedures are effective to provide reasonable assurance that information the Company is required to disclose in its reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, including, without limitation, ensuring that such information is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
There have been no changes in the Company’s internal control over financial reporting during the quarter ended June 30, 2012 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Risk factors
As filed, 208 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no changes to the risk factors included in our 2011 Form 10-K, as modified by the changes to those risk factors included in other reports we filed with the SEC subsequent to February 24, 2012.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-04-01 to 2012-06-30 | $9.70bn | us-gaap:Revenues |
| Revenue | 6 months2012-01-01 to 2012-06-30 | $19.92bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2012-04-01 to 2012-06-30 | $1.38bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2012-01-01 to 2012-06-30 | $2.77bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-04-01 to 2012-06-30 | $590.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2012-01-01 to 2012-06-30 | $1.01bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2012-04-01 to 2012-06-30 | $26.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2012-01-01 to 2012-06-30 | $52.0m | us-gaap:InterestExpense |
| Income tax | 3 months2012-04-01 to 2012-06-30 | $208.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2012-01-01 to 2012-06-30 | $350.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-04-01 to 2012-06-30 | $356.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2012-01-01 to 2012-06-30 | $604.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-04-01 to 2012-06-30 | $2.16 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2012-01-01 to 2012-06-30 | $3.65 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-04-01 to 2012-06-30 | $2.19 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2012-01-01 to 2012-06-30 | $3.70 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-04-01 to 2012-06-30 | 164,639,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2012-01-01 to 2012-06-30 | 165,363,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2012-01-01 to 2012-06-30 | $3.05bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2012-01-01 to 2012-06-30 | $185.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2012-01-01 to 2012-06-30 | $82.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2012-01-01 to 2012-06-30 | $278.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2012-06-30 | $3.87bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-06-30 | $14.07bn | us-gaap:AssetsCurrent |
| Total assets | At period end2012-06-30 | $20.86bn | us-gaap:Assets |
| Current liabilities | At period end2012-06-30 | $8.68bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-06-30 | $12.40bn | us-gaap:Liabilities |
| Long-term debt | At period end2012-06-30 | $1.62bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2012-06-30 | $8.46bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2012-06-30 | 161,712,439 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-12-327550. Last ingested by Listed: Nov 13, 2026, 14:11 ET. Listed shows no prices and gives no investment advice.